Avalon GloboCare (ALBT) Cash & Equivalents (2015 - 2026)

Avalon GloboCare's Cash & Equivalents history runs 12 years deep, the most recent figure standing at $775995.0 for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 27.65% year-over-year to $775995.0 in Q1 2026; TTM through Mar 2026 was $775995.0, a 27.65% decrease from a year earlier, with the FY2025 full-year figure at $109091.0, down 95.9% from the prior year.
• Cash & Equivalents climbed to $775995.0 in Q1 2026 per ALBT's latest filing, from $109091.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.9 million in Q3 2022 and bottomed at $76491.0 in Q4 2023.
• The 5-year median for Cash & Equivalents is $653191.0 (2023), against an average of $955289.3.
• Across the five-year window, Cash & Equivalents plunged 96.16% in 2023 and soared 3375.16% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $2.0 million in 2022, then plunged by 96.16% to $76491.0 in 2023, then surged by 3375.16% to $2.7 million in 2024, then slumped by 95.9% to $109091.0 in 2025, then soared by 611.33% to $775995.0 in 2026.
• Per Business Quant, the three latest ALBT Cash & Equivalents figures stand at $775995.0 (Q1 2026), $109091.0 (Q4 2025), and $250000.0 (Q3 2025).